Should the Dosage Cap Be Used in Patients Greater than 100 kg Receiving N-acetylcysteine for Acetaminophen Toxicity?
- PMID: 35006546
- PMCID: PMC8758859
- DOI: 10.1007/s13181-021-00871-2
Should the Dosage Cap Be Used in Patients Greater than 100 kg Receiving N-acetylcysteine for Acetaminophen Toxicity?
Keywords: Acetaminophen; Capped dosing; Hepatotoxicity; NAC; Obesity.
Conflict of interest statement
All authors declare that they have no conflict of interest.
Figures
Comment in
-
The Cents of the Dosage Cap in Patients Greater than 100 Kilograms Receiving N-Acetylcysteine for Acetaminophen Toxicity.J Med Toxicol. 2022 Jan;18(1):67-68. doi: 10.1007/s13181-021-00872-1. Epub 2022 Jan 10. J Med Toxicol. 2022. PMID: 35006548 Free PMC article. No abstract available.
Comment on
-
Evaluation of Dosing Strategies of N-acetylcysteine for Acetaminophen Toxicity in Patients Greater than 100 Kilograms: Should the Dosage Cap Be Used?J Med Toxicol. 2021 Jul;17(3):241-249. doi: 10.1007/s13181-021-00822-x. Epub 2021 Apr 21. J Med Toxicol. 2021. PMID: 33884558 Free PMC article.
References
-
- Baum RA, Woolum JA, Bailey AM, Howell MM, Weant KA, Geraghty L, Mohan S, Webb AN, Su MK, Akpunonu P, Amirshahi M. Evaluation of dosing strategies of N-acetylcysteine for acetaminophen toxicity in patients greater than 100 kilograms: should the dosage cap be used? J Med Toxicol. 2021;17:241–249. doi: 10.1007/s13181-021-00822-x/Published. - DOI - PMC - PubMed
-
- ACETADOTE (acetylcysteine) injection (package insert). Nashville, TN; Cumberland Pharmaceuticals Inc; 2019. https://www.acetadote.com/New_Acetadote_Labeling_25OCT2019.pdf. Accessed 30 Oct 2021.
-
- Cumberland Pharmaceuticals Inc. ACETADOTE (acetylcysteine) injection (package insert). U.S. Food and Drug Administration. website: https://www.accessdata.fda.gov/drugsatfda_docs/nda/2004/21-539_Acetadote.... Revised January 2004
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
